Carole Green

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

Martin Dennis, Gillian Mead, John Forbes et al. · The Lancet · 2018 · 286 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock et al. · The Lancet · 2019 · 195 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype

Belinda K. Singleton, Nicholas M. Burton, Carole Green et al. · Blood · 2008 · 167 citations

Life Sciences, Genetics, Molecular Genetics +7

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

Michael Mullen, Xu Yu Jin, Anne H. Child et al. · The Lancet · 2019 · 133 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Comparison of the Proteome of Adult and Cord Erythroid Cells, and Changes in the Proteome Following Reticulocyte Maturation

Marieangela C. Wilson, Kongtana Trakarnsanga, Kate J. Heesom et al. · Molecular & Cellular Proteomics · 2016 · 95 citations · Full text

Life Sciences, Biochemistry, Hematology +14